These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 19513522

  • 21. A panel of artificial APCs expressing prevalent HLA alleles permits generation of cytotoxic T cells specific for both dominant and subdominant viral epitopes for adoptive therapy.
    Hasan AN, Kollen WJ, Trivedi D, Selvakumar A, Dupont B, Sadelain M, O'Reilly RJ.
    J Immunol; 2009 Aug 15; 183(4):2837-50. PubMed ID: 19635907
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Dendritic cells cross-talk with tumour antigen-specific CD8+ T cells, Vγ9γδT cells and Vα24NKT cells in patients with glioblastoma multiforme and in healthy donors.
    Eiraku Y, Terunuma H, Yagi M, Deng X, Nicol AJ, Nieda M.
    Clin Exp Immunol; 2018 Oct 15; 194(1):54-66. PubMed ID: 30009488
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The in vitro generation of Ph1+ ALL-specific HLA-A24-restricted cytotoxic T lymphocytes using a synthetic 16 mer minor bcr-abl peptide.
    Hagihara M, Tsuchiya T, Hyodo O, Ueda Y, Tazume K, Gansuvd B, Kato S, Hotta T.
    Leuk Res; 2003 Mar 15; 27(3):253-7. PubMed ID: 12537978
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Ex vivo stimulation of cytomegalovirus (CMV)-specific T cells using CMV pp65-modified dendritic cells as stimulators.
    Carlsson B, Cheng WS, Tötterman TH, Essand M.
    Br J Haematol; 2003 May 15; 121(3):428-38. PubMed ID: 12716365
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Promiscuous CTL recognition of viral epitopes on multiple human leukocyte antigens: biological validation of the proposed HLA A24 supertype.
    Burrows SR, Elkington RA, Miles JJ, Green KJ, Walker S, Haryana SM, Moss DJ, Dunckley H, Burrows JM, Khanna R.
    J Immunol; 2003 Aug 01; 171(3):1407-12. PubMed ID: 12874232
    [Abstract] [Full Text] [Related]

  • 34. Strategic use of an adenoviral vector for rapid and efficient ex vivo-generation of cytomegalovirus pp65-reactive cytolytic and helper T cells.
    Forsberg O, Carlsson B, Tötterman TH, Essand M.
    Br J Haematol; 2008 Apr 01; 141(2):188-99. PubMed ID: 18307565
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
    Albiero E, Amati E, Baumeister E, Einsele H, Grigoleit GU, Rodeghiero F.
    J Immunother; 2016 Apr 01; 39(9):329-342. PubMed ID: 27631893
    [Abstract] [Full Text] [Related]

  • 37. Characterization of cytotoxic function of CMV-pp65-specific CD8+ T-lymphocytes identified by HLA tetramers in recipients and donors of stem-cell transplants.
    Lacey SF, Gallez-Hawkins G, Crooks M, Martinez J, Senitzer D, Forman SJ, Spielberger R, Zaia JA, Diamond DJ.
    Transplantation; 2002 Sep 15; 74(5):722-32. PubMed ID: 12352893
    [Abstract] [Full Text] [Related]

  • 38. Generation of tumor-specific CTLs from melanoma patients by using peripheral blood stimulated with allogeneic melanoma tumor cell lines. Fine specificity and MART-1 melanoma antigen recognition.
    Stevens EJ, Jacknin L, Robbins PF, Kawakami Y, el Gamil M, Rosenberg SA, Yannelli JR.
    J Immunol; 1995 Jan 15; 154(2):762-71. PubMed ID: 7814882
    [Abstract] [Full Text] [Related]

  • 39. Crisscross CTL induction by SYT-SSX junction peptide and its HLA-A*2402 anchor substitute.
    Ida K, Kawaguchi S, Sato Y, Tsukahara T, Nabeta Y, Sahara H, Ikeda H, Torigoe T, Ichimiya S, Kamiguchi K, Wada T, Nagoya S, Hiraga H, Kawai A, Ishii T, Araki N, Myoui A, Matsumoto S, Ozaki T, Yoshikawa H, Yamashita T, Sato N.
    J Immunol; 2004 Jul 15; 173(2):1436-43. PubMed ID: 15240740
    [Abstract] [Full Text] [Related]

  • 40. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
    Nair SK, De Leon G, Boczkowski D, Schmittling R, Xie W, Staats J, Liu R, Johnson LA, Weinhold K, Archer GE, Sampson JH, Mitchell DA.
    Clin Cancer Res; 2014 May 15; 20(10):2684-94. PubMed ID: 24658154
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.